ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 105 filers reported holding ARATANA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,859,000 | +12.8% | 747,822 | -21.3% | 0.00% | 0.0% |
| Q1 2019 | $3,420,000 | -24.7% | 950,001 | +28.2% | 0.00% | -50.0% |
| Q4 2018 | $4,544,000 | +4.2% | 741,268 | -0.8% | 0.00% | +100.0% |
| Q3 2018 | $4,362,000 | +49.6% | 747,074 | +8.9% | 0.00% | 0.0% |
| Q2 2018 | $2,915,000 | +3.4% | 685,759 | +7.2% | 0.00% | 0.0% |
| Q1 2018 | $2,820,000 | +16.1% | 639,436 | +38.5% | 0.00% | 0.0% |
| Q4 2017 | $2,428,000 | +7.8% | 461,612 | +25.7% | 0.00% | 0.0% |
| Q3 2017 | $2,252,000 | +2.5% | 367,365 | +20.8% | 0.00% | 0.0% |
| Q2 2017 | $2,197,000 | +50.1% | 303,988 | +10.1% | 0.00% | – |
| Q1 2017 | $1,464,000 | +181.5% | 276,152 | +281.4% | 0.00% | – |
| Q4 2016 | $520,000 | +100.8% | 72,414 | +161.5% | 0.00% | – |
| Q3 2016 | $259,000 | +10.7% | 27,697 | -25.3% | 0.00% | – |
| Q2 2016 | $234,000 | +33.0% | 37,067 | +15.9% | 0.00% | – |
| Q1 2016 | $176,000 | +188.5% | 31,975 | +196.7% | 0.00% | – |
| Q4 2015 | $61,000 | -28.2% | 10,776 | +6.9% | 0.00% | – |
| Q3 2015 | $85,000 | -38.4% | 10,076 | +10.9% | 0.00% | – |
| Q2 2015 | $138,000 | +137.9% | 9,087 | +155.4% | 0.00% | – |
| Q1 2015 | $58,000 | +107.1% | 3,558 | +132.2% | 0.00% | – |
| Q4 2014 | $28,000 | +115.4% | 1,532 | +15.8% | 0.00% | – |
| Q3 2014 | $13,000 | -91.6% | 1,323 | -86.7% | 0.00% | – |
| Q2 2014 | $155,000 | +4.0% | 9,960 | +24.4% | 0.00% | – |
| Q1 2014 | $149,000 | +1762.5% | 8,009 | +1902.2% | 0.00% | – |
| Q4 2013 | $8,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|